Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KJ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,626
Award facts
- Contract value 100% obligated
- $53,626.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $53,626.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalation medication (60-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
TRELEGY ELLIPTA is a combination maintenance inhalation medication used in respiratory care, and this order supports the Defense Logistics Agency's mission to supply essential pharmaceutical products to military treatment facilities and veterans' healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements through its extensive portfolio of competitively awarded contracts with DLA covering diverse therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9KJ4?
SPE2DR26F9KJ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9KJ4 worth?
The government has obligated $53,626 on SPE2DR26F9KJ4.
Is contract SPE2DR26F9KJ4 an order under another contract?
Yes. SPE2DR26F9KJ4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KJ4 competed?
The extent of competition for SPE2DR26F9KJ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award